Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic

The coronavirus disease of 2019 (COVID-19) has posed a major challenge for providers and patients. A large number of patients with atrial fibrillation, venous thromboembolism, or valvular heart disease are chronically anticoagulated with vitamin K antagonists and rely on frequent follow ups at antic...

Full description

Bibliographic Details
Main Authors: Kaveh Rezaei Bookani MD, Iva Minga MD, Manisha Chander PharmD, Ksenia Hankewych PharmD, Matthew Plassmeier PharmD, Alfonso Tafur MD, MS
Format: Article
Language:English
Published: SAGE Publishing 2020-08-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/1076029620947476